Dublin, June 17, 2019 (GLOBE NEWSWIRE) -- The "Prostate Cancer Therapeutics: Global Market Analysis, Trends, and Forecasts" report has been added to ResearchAndMarkets.com's offering. This report provides separate comprehensive analytics for the US, Canada, Europe, and Rest of World. Annual estimates and forecasts are provided for the period 2015 through 2022. Also, a six-year historic analysis is provided for these markets.The report analyzes the worldwide markets for Prostate Cancer Therapeutics in US$ Million by the following Segments: Hormone Therapy, and Other Therapies. The report profiles 76 companies including many key and niche players such as:

Key Topics Covered1. INDUSTRY OVERVIEWAn Insight in the Global Market for Prostate Cancer Diagnostics and TherapeuticsRising Incidence of Prostate Cancer: Cornerstone for the MarketCurrent & Future AnalysisDeveloped Markets: Traditional Revenue ContributorsDeveloping Countries Turbo Charge Future Market GrowthAn Insight into the Castration-Resistant Prostate Cancer Therapeutics MarketMarket Outlook & TrendsZytiga (Abiraterone acetate): The Market LeaderSelect Drugs that Received Approval for Castration-Resistant Prostate Cancer (CRPC)Hormone Therapies to Dominate Global Prostate Cancer Therapeutics MarketKey Prostate Cancer Hormone Therapy Drugs & Companies: 2017Targeted TherapyThe New Frontier of Cancer TreatmentRadiotherapyGaining ProminenceMetastatic Prostate CancerApt for Precision OncologyLaunch of Generic Drugs to Place Established Players in JeopardyDemographics & Lifestyles Raise the Risk of Prostate CancerSelect General Risk Factors and their Relative Risk Rate in Prostate CancerSmall Cap Companies: A Target of Private Capital FinancingCost Analysis of Currently Available TreatmentGrowth DriversRise in Prostate Cancer Incidence & Access to Modern Therapeutics Foster GrowthImproved Screening, Diagnosis & Patient Survival Rates Trigger GrowthAwareness Drives European Prostate Cancer Therapeutics MarketMinimally Invasive Devices to Gain Share in Emerging MarketsSupportive Cancer Drugs Contribute to GrowthSelect FDA Approved Drugs for Palliative Treatment of Advanced Prostate CancerDevelopments in Proteomics Favor MarketMolecular Imaging of Cancer: Critical in Improving Patient OutcomesGrowth RestraintsCostly & Complicated Treatment Protocols: A Major Stumbling Block in Patient ComplianceLimited Tumor Specificity and ToxicityMultiple Drug ResistanceStringent Regulations Delay Market ApprovalChallenges Faced by Patients and Clinicians in Diagnosis and TreatmentChallenges Encountered in Clinical TrialsSelect Recent Prostate Cancer Drug Trial FailuresHigh Development Costs Retracts Manufacturers in Developing CountriesPipeline of Drugs in Clinical TrialsNew Products to Bolster Sales of Prostate Cancer TherapeuticsSelect Prostate Cancer Drugs in the Pipeline (2018)Marine Sponge-Derived Compound Shows Promise against Prostate CancerNew Combination Treatment for Advanced mCRPCRisk of Alzheimer's dampens the MarketInnovations & AdvancementsResearch and Development FindingsAdditional Tests to be used with PSA for Better Diagnosis of Prostate CancerNew Approaches in Diagnosis and Staging of Prostate CancerNew Developments in Treatment Methods and Diet StrategiesInnovative mCRPC Treatment Options to Enhance Quality of LifeNew Drug Class (sphingolipid pathway inhibitor) Shows Potential for Slowing down GrowthNeural Stem Cell Therapy: Revolutionary Step to Combat CancerAilanthone Identified as Potential Therapeutic for the Treatment of CRPCLaser Activated Treatment for Prostate Cancer DevelopedPhotodynamic Therapy Offers Potential to Treat Prostate CancerCombination of Therapies under ResearchFuture Research Strategies to Benefit from Open Access PublishingInnovations in Drug Delivery: A Key Factor in Product Differentiation2. PRODUCT OVERVIEWCancer: A Major Health Crisis in the Modern WorldProstateStructurePituitary GlandTestesProstate CancerA PrimerKey FactsScreening/Detection of Prostate CancerDigital Rectal Exam (DRE)Transrectal Ultrasound (TRUS)PSA Blood TestStrategies to Enhance Screening/Detection of Prostate CancerImproved PSA TestingTotal PSA, Free PSA and PSA-Alpha-1-Protease Inhibitor LevelsInsulin-like Growth Factor (IGF-1) and Intact IGF-Binding Protien-3 (IGF-BP3)GSTP1 Methylation Levels and Prostate Cancer DiagnosisMicrobubble UltrasoundStaging of Prostate CancerGleason ScoreGleason Score and Grading of Prostate CancerTNM StagingT-Staging Analysis of Prostate CancerGenetic & Non-Genetic FactorsHereditary or Genetic FactorsNon-Genetic or Environmental FactorsPrevention of CancerRole of Diet in Prostate CancerTreatment Options for Prostate CancerHormonal TherapyMedical Hormone TherapyLHRH AnalogsDose of LHRH Agonists for Advance Prostate Carcinoma TreatmentAnti-AndrogensAnti-Androgen MonotherapyOrchiectomySide Effects of OrchiectomyTime to Start Hormonal TherapyStrategies to Enhance Hormonal TreatmentCombination TherapyIntermittent TherapyRadiation TherapyBrachytherapyTreatment ProcedureBenefits of BrachytherapyDrawbacks of BrachytherapyHigh Dose Rate (HDR) BrachytherapyExternal Beam Radiation Therapy (EBRT)Side Effects of RadiotherapyStrategies to Enhance Radiation TreatmentChemotherapyRisks Associated with ChemotherapySurgical Procedures for Prostate CancerTransurethral Resection of the Prostate (TURP)Prostatectomy and Lymph Node DissectionRadical ProstatectomyCryosurgeryAdvantages of Cryosurgery:Disadvantages of Cryosurgery:Other Treatment OptionsIntensity Modulated Radiation Therapy (IMRT)Benefits of IMRTDrawbacks of IMRTAndrogen Deprivation Therapy (ADT)High Dose Radiation (HDR) MonotherapyDrawbacks of HRDChoosing the Optimal Treatment MethodRecurrent Prostate CancerRecurrent Prostate Cancer Subsequent to SurgeryRecurrent Prostate Cancer Subsequent to Radiation TherapyHormone-Refractory Prostate Cancer (HRPC)Select Drugs for Hormone-Refractory Prostate CancerChemotherapyTaxotere (Docetaxel)Bone Complication TreatmentsBisphosphonate DrugsRadiation TherapyStrategies to Enhance Recurrent Prostate Cancer TreatmentChemotherapyNew RegimensPhase I Clinical TrialsCombination TherapyGene TherapyTargeted TherapySelective Endothelia A Receptor Antagonist(SERA)Other Select Targeted TherapiesTyrosine Kinase InhibitorsAnti-Angiogenic DrugsMonoclonal AntibodiesVaccinesRadioactive Monoclonal AntibodiesDistribution Channels3. DRUG APPROVALS AND CLINICAL STUDIESJanssen Biotech Receives Approval for ErleadaJanssen Pharmaceutical Bags Approval for ZYTIGA for Metastatic High-Risk CSPCJanssen Biotech Submits Supplemental NDA for ZYTIGA to Treat Early Stage Metastatic Prostate CancerBavarian Nordic to Discontinue Phase 3 PROSPECT Study on mCRPCBavarian Nordic Announces Phase 2 Clinical Trial of PROSTVACOncBioMune Pharmaceuticals Offers Latest Clinical Data of ProscaVaxPfizer and Astellas Pharma Announces Phase 3 PROSPER Trial Results of XTANDIEMA Issues Positive Opinion to Include Data in European Label for XTANDICofepris Approves Weizmann Institute Drug TOOKAD SolubleOncBioMune Pharmaceuticals Reports Positive Phase 1 Results of ProscaVaxFDA Accepts Xtandi sNDA by Astellas Pharma for ReviewProgenics Pharmaceuticals Begins Phase 3 Clinical Trial Enrollment for 1404FDA Grants Astrazeneca's Lynparza Breakthrough Therapy DesignationNanobiotix's Investigational New Drug NBTXR3 Set for First Clinical TrialMinomic International to Launch Human Trial of Its MAb TechnologyTakeda Receives NDA Approval for LeuplinProgenics Enters into Licensing Agreement with Johns Hopkins for Clinical-Stage PSMA AgentZYTIGA Receives FDA Approval for Label UpdateValeant Reports Long-Term results of Phase II STAND Trial of PROVENGEOncoGeneX Pharmaceuticals to Regain Rights on Experimental Drug Custirsen from Teva4. PRODUCT LAUNCHESQIAGEN Commercializes AdnaTest Prostate Cancer Panel AR-V7 for Research UseGenomeDx Biosciences Launches Decipher Biopsy Test for Prostate CancerProfound Medical and Siemens Sign Agreement to Launch TULSA- PROTM SystemAeterna Zentaris Begins Promotional Activities for APIFINY TestBiocept Launches Androgen Receptor Expression Assay for Prostate Cancer DetectionAugmenix Reports Robust Commercial Uptake of SpaceOAR System during RadiotherapyMDxHealth SA Launches SelectMDx Test in EuropeBayer Launches Xofigo in Ontario5. RECENT INDUSTRY ACTIVITYValeant Pharmaceuticals International to Divest Dendreon Pharmaceuticals to Sanpower GroupAbbVie Enters into Immuno-Oncology Research Collaboration with Harpoon TherapeuticsAstraZeneca Inks Pact with TerSera TherapeuticsBristol-Myers Squibb and Clovis Oncology Ink a Broad Clinical Collaboration AgreementJ&J Expands Market for ZytigaTelix Pharmaceuticals Completes Product Collaboration and Purchase Option Agreement with Atlab PharmaUCLA Sells Xtandi Rights to Royalty PharmaAytu BioScience Enters into Study Agreement with Hybridyne Imaging TechnologiesCrown Bioscience Signs Licensing Agreement with University of York for PDX ModelsHologic Acquires DiagnoCure's Prostate Cancer Biomarker AssetsAeterna Zentaris Enters into Co-Marketing Agreement with ArmuneExiqon Acquires Licensing Rights on Prostate Cancer Biomarkers from University HospitalMylan Sued for ANDA for Generic Version of ZytigaAytu BioScience Acquires Jazz Pharmaceuticals' rights to ProstaScintOPKO Health to Acquire Bio-Reference LaboratoriesBoston Scientific to Acquire American Medical Systems' Urology PortfolioValeant to Acquire Dendreon's Assets6. FOCUS ON SELECT GLOBAL PLAYERS7. GLOBAL MARKET PERSPECTIVESegmental AnalyticsIII. MARKET1. THE UNITED STATESA.Market AnalysisA Surging US Prostate Cancer Therapeutics MarketProstate Cancer Stats: Opportunity IndicatorHormone Therapy Dominates Prostate Cancer Drugs MarketHigh Intensity Focused Ultrasound (HIFU) Approved for Ablation of Prostate TissueDrug Approvals and Clinical StudiesProduct LaunchesStrategic Corporate DevelopmentsSelect Key PlayersB.Market Analytics2. CANADAA.Market AnalysisProstate Cancer Stats: Opportunity IndicatorsClinical TrialProduct LaunchesStrategic Corporate DevelopmentsB.Market Analytics3. EUROPEA.Market AnalysisAwareness Drives European Prostate Cancer Therapeutics MarketHIFU Technology Gaining Momentum in EuropeB.Market Analytics3a. FRANCEA.Market AnalysisSanofi S.A.A Key France-based PlayerB.Market Analytics3b. GERMANYA.Market AnalysisProduct LaunchSelect Key PlayerB.Market Analytics3c. ITALYMarket Analysis3d. THE UNITED KINGDOMA.Market AnalysisProstate Cancer Research in UKAn InsightNeed for Filling up Gaps in Provision of CareDearth of Clinical ResearchersSelect Key PlayersB.Market Analytics3e. SPAINMarket Analysis3f. REST OF EUROPEA.Market AnalysisClinical StudiesProduct LaunchStrategic Corporate DevelopmentSelect Key PlayersB.Market Analytics4. REST OF WORLDA.Market AnalysisMinimally Invasive Devices to Gain Share in Emerging MarketsCancer Market in AsiaAustraliaIndiaClinical TrialsSelect Key PlayersB.Market AnalyticsIV. COMPETITIVE LANDSCAPE



The United States (47)Canada (6)Japan (4)Europe (23) - France (5) - Germany (3) - The United Kingdom (5) - Rest of Europe (10)Asia-Pacific (Excluding Japan) (4)

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Anti-Wrinkle

CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900Related Topics: Prostate Cancer Drugs

.gnwlistitemmarginbottom {margin-bottom: 10.0px !important;} .gnwtablebottommargin {margin-bottom: 10.0px !important;} .gnwcellpaddingleft0 {padding-left: 0.0px !important;} .gnwverticalaligntop {vertical-align: top !important;} .gnwtextaligncenter {text-align: center !important;} .gnwcellparagraphmargin {margin-bottom: 0px !important; margin-top: 0px !important;} .gnwverticalalignbottom {vertical-align: bottom !important;} .gnwwhitespacenowrap {white-space: nowrap !important;} .gnwtextalignright {text-align: right !important;} .gnwcellpaddingright0 {padding-right: 0.0px !important;} .gnwunderlinestyle {text-decoration: underline !important;} .gnwtextalignleft {text-align: left !important;} .gnw_ol {position: relative !important; left: 10px !important;} .gnw_ul {position: relative !important; left: 10px !important;} .gnw_table_border_collapse td {font-size: 12px !important; line-height: 1.25em !important;} .gnw_border_top_solid {border-top: solid black 1px !important;} .gnw_border_right_solid {border-right: solid black 1px !important;} .gnw_border_bottom_solid {border-bottom: solid black 1px !important;} .gnw_border_left_solid {border-left: solid black 1px !important;} .gnw_border_top_double {border-top: double black 3px !important;} .gnw_border_right_double {border-right: double black 3px !important;} .gnw_border_bottom_double {border-bottom: double black 3px !important;} .gnw_border_left_double {border-left: double black 3px !important;} .gnw_table_border_collapse {border-collapse: collapse !important;} .gnw_align_left {text-align: left !important;} .gnw_align_center {text-align: center !important;} .gnw_align_right {text-align: right !important;} .gnw_align_justify {text-align: justify !important;} .gnw_vertical_align_top {vertical-align: top !important;} .gnw_vertical_align_middle {vertical-align: middle !important;} .gnw_vertical_align_bottom {vertical-align: bottom !important;} .gnw_padding_left_none {padding-left: 0 !important;} .gnw_padding_right_none {padding-right: 0 !important;} .gnw_table_border_collapse td.gnw_align_left {padding-left: 0 !important;padding-right: 3px !important;} .gnw_table_border_collapse td.gnw_align_right {padding-left: 3px !important;padding-right: 0 !important;} .gnw_heading {font: 16px Arial; text-align: center !important;} .gnw_subhead {font: 12px Arial; text-align: center !important;} .gnw_colhead {font: 12px Arial; text-align: center !important;} .gnw_colhead_uline {font: 12px Arial; text-align: center !important; border-bottom: solid black 1.0pt;} .gnw_colhead_dline {font: 12px Arial; text-align: center !important; border-bottom: double black 2.5pt;} .gnw_label {font: 12px Arial; vertical-align: bottom !important; text-align: left !important;} .gnw_label_uline {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: solid black 1.0pt;} .gnw_label_uline_i10 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: solid black 1.0pt; padding-left: 10.0px;} .gnw_label_uline_i15 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: solid black 1.0pt; padding-left: 15.0px;} .gnw_label_uline_i20 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: solid black 1.0pt; padding-left: 20.0px;} .gnw_label_uline_i25 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: solid black 1.0pt; padding-left: 25.0px;} .gnw_label_uline_i30 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: solid black 1.0pt; padding-left: 30.0px;} .gnw_label_dline_i10 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: double black 2.5pt; padding-left: 10.0px;} .gnw_label_dline_i15 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: double black 2.5pt; padding-left: 15.0px;} .gnw_label_dline_i20 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: double black 2.5pt; padding-left: 20.0px;} .gnw_label_dline_i25 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: double black 2.5pt; padding-left: 25.0px;} .gnw_label_dline_i30 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: double black 2.5pt; padding-left: 30.0px;} .gnw_label_ulinetop {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-top: solid black 1.0pt;} .gnw_label_dline {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: double black 2.5pt;} .gnw_label_i10 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; padding-left: 10.0px;} .gnw_label_i15 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; padding-left: 15.0px;} .gnw_label_i20 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; padding-left: 20.0px;} .gnw_label_i25 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; padding-left: 25.0px;} .gnw_label_i30 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; padding-left: 30.0px;} .gnw_num {font: 12px Arial; vertical-align: bottom !important; text-align: right !important; white-space: nowrap !important;} .gnw_num_uline {font: 12px Arial; vertical-align: bottom !important; text-align: right !important; white-space: nowrap !important; border-bottom: solid black 1.0pt;} .gnw_num_ulinetop {font: 12px Arial; vertical-align: bottom !important; text-align: right !important; white-space: nowrap !important; border-top: solid black 1.0pt;} .gnw_num_dline {font: 12px Arial; vertical-align: bottom !important; text-align: right !important; white-space: nowrap !important; border-bottom: double black 2.5pt;} .gnw_num_dlinetop {font: 12px Arial; vertical-align: bottom !important; text-align: right !important; white-space: nowrap !important; border-top: double black 2.5pt;} .gnw_data {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; white-space: nowrap !important;} .gnw_data_uline {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: solid black 1.0pt;} .gnw_data_dline {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: double black 2.5pt;} .gnw_news_media_box {margin-top: 15px !important; margin-left: 6px !important; margin-bottom: 6px !important; margin-right: 6px !important; border-width: 1px !important; border-color: #A9A9A9 !important; border-style: solid !important;} .gnw_media_caption {font-size: 8pt !important; font-family: Verdana, Arial, Helvetica, Geneva, Swiss, SunSans-Regular !important;} .gnw_media_bgcolor {background-color: transparent !important;} .gnw_table {border-collapse: separate !important; border-spacing: 6px !important;} .gnw_videotitle {font: bold 12px Arial !important; color: #1d5296 !important;} td.gnw_heading {font: 16px Arial; text-align: center !important;} td.gnw_subhead {font: 12px Arial; text-align: center !important;} td.gnw_colhead {font: 12px Arial; text-align: center !important;} td.gnw_colhead_uline {font: 12px Arial; text-align: center !important; border-bottom: solid black 1.0pt;} td.gnw_colhead_dline {font: 12px Arial; text-align: center !important; border-bottom: double black 2.5pt;} td.gnw_label {font: 12px Arial; vertical-align: bottom !important; text-align: left !important;} td.gnw_label_uline {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: solid black 1.0pt;} td.gnw_label_uline_i10 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: solid black 1.0pt; padding-left: 10.0px;} td.gnw_label_uline_i15 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: solid black 1.0pt; padding-left: 15.0px;} td.gnw_label_uline_i20 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: solid black 1.0pt; padding-left: 20.0px;} td.gnw_label_uline_i25 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: solid black 1.0pt; padding-left: 25.0px;} td.gnw_label_uline_i30 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: solid black 1.0pt; padding-left: 30.0px;} td.gnw_label_dline_i10 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: double black 2.5pt; padding-left: 10.0px;} td.gnw_label_dline_i15 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: double black 2.5pt; padding-left: 15.0px;} td.gnw_label_dline_i20 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: double black 2.5pt; padding-left: 20.0px;} td.gnw_label_dline_i25 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: double black 2.5pt; padding-left: 25.0px;} td.gnw_label_dline_i30 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: double black 2.5pt; padding-left: 30.0px;} td.gnw_label_ulinetop {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-top: solid black 1.0pt;} td.gnw_label_dline {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: double black 2.5pt;} td.gnw_label_i10 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; padding-left: 10.0px;} td.gnw_label_i15 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; padding-left: 15.0px;} td.gnw_label_i20 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; padding-left: 20.0px;} td.gnw_label_i25 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; padding-left: 25.0px;} td.gnw_label_i30 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; padding-left: 30.0px;} td.gnw_num {font: 12px Arial; vertical-align: bottom !important; text-align: right !important; white-space: nowrap !important;} td.gnw_num_uline {font: 12px Arial; vertical-align: bottom !important; text-align: right !important; white-space: nowrap !important; border-bottom: solid black 1.0pt;} td.gnw_num_ulinetop {font: 12px Arial; vertical-align: bottom !important; text-align: right !important; white-space: nowrap !important; border-top: solid black 1.0pt;} td.gnw_num_dline {font: 12px Arial; vertical-align: bottom !important; text-align: right !important; white-space: nowrap !important; border-bottom: double black 2.5pt;} td.gnw_num_dlinetop {font: 12px Arial; vertical-align: bottom !important; text-align: right !important; white-space: nowrap !important; border-top: double black 2.5pt;} td.gnw_data {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; white-space: nowrap !important;} td.gnw_data_uline {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: solid black 1.0pt;} td.gnw_data_dline {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: double black 2.5pt;} td.gnw_media_caption {font-size: 8pt !important; font-family: Verdana, Arial, Helvetica, Geneva, Swiss, SunSans-Regular !important;} td.gnw_videotitle {font: bold 12px Arial !important; color: #1d5296 !important;} ;}

HIFU machine, Aqua dermarbrasion, Diamond dermabrasion - Maxbeauty,http://www.mymaxbeauty.com/